Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000327809 | SCV000329187 | uncertain significance | not provided | 2016-02-26 | criteria provided, single submitter | clinical testing | The P277L variant in the CACNA1H gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The P277L variant was not observed at any significant frequency in approximately 6,300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The P277L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret P277L as a variant of uncertain significance. |
Fulgent Genetics, |
RCV000764011 | SCV000894963 | uncertain significance | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003765577 | SCV004568900 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2023-10-09 | criteria provided, single submitter | clinical testing |